20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Docetaxel Anhydrous in Breast Cancer Treatment: A Critical Overview

Breast cancer remains one of the most prevalent and challenging cancers globally, necessitating sophisticated treatment strategies. Among the arsenal of chemotherapeutic agents, Docetaxel Anhydrous has emerged as a critical component, particularly for advanced or metastatic stages where initial treatments may have failed.

Docetaxel Anhydrous, recognized for its potent cytotoxic activity, functions as a microtubule inhibitor. This mechanism is vital in combating cancer cells, as it disrupts the normal process of cell division. By stabilizing microtubules, it prevents cancer cells from undergoing mitosis, ultimately leading to their demise. This targeted action makes it a powerful tool against rapidly proliferating cancer cells characteristic of breast cancer.

The docetaxel anhydrous medical uses extensively cover breast cancer treatment. It is often administered to patients who have previously undergone chemotherapy that proved ineffective. In certain cases, it is used in combination with other chemotherapy agents, such as doxorubicin and cyclophosphamide, to enhance therapeutic outcomes in operable node-positive breast cancer. The precise dosing and administration protocols, informed by detailed docetaxel anhydrous pharmacokinetic data, are crucial for maximizing efficacy and managing potential adverse effects.

While Docetaxel Anhydrous offers significant benefits, it is important to be aware of its potential side effects and drug interactions. Understanding these aspects is key to patient care and management. NINGBO INNO PHARMCHEM CO.,LTD. provides high-quality Docetaxel Anhydrous, supporting the pharmaceutical industry in delivering these essential treatments. Our commitment to quality ensures that healthcare providers have access to reliable APIs for developing effective breast cancer therapies.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Microtubule Inhibitors: Focusing on Docetaxel Anhydrous

Next: Navigating the Pharmacokinetics of Docetaxel Anhydrous

All Rights Reserved